BSP collaborative research exploring economic impact of intravenous fluid choices for cardiac surgery on display at ISPOR 2016 today


(Washington DC, May 23rd 2016): Patients undergoing cardiac surgery (CS) routinely receive intravenous (IV) crystalloids perioperatively (during and immediately post-surgery). However, perioperative use of calcium-free balanced IV crystalloids was associated with lower costs among CS patients according to a study produced by a research team comprising of Boston Strategic Partners, Inc. (BSP) researchers: Dr. Fred Peyerl and Dr. Victor Khangulov and Duke University researcher Dr. Karthik Ragunathan and Vanderbilt University researcher Dr. Andrew Shaw.

The presentation will be on display at ISPOR today between 8.30 am and 2.15 pm. The poster author discussion hour is scheduled at 1.15pm to 2.15 pm. Visit the authors at booth 32 to learn more about the association between perioperative crystalloid choice and treatment costs among adults undergoing cardiac surgery. The research is supported by detailed analyses of EHR database which contains information about 60 million unique patients over a 15 year timeframe. More information on this database can be found here.

Please check out our events section for the full list of presentation titles and timetable.

To schedule a meeting with our team, please email us at We look forward to discussing ideas and insights on health economics and outcomes research and ways to support your business and clinical needs.


Founded in 1995 as an international multidisciplinary professional membership society, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) advances the policy, science, and practice of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes).